After a nearly 21-year career in the FBI, Roberts joined Bristol Myers Squibb in April, 2020, and has spent the past 7 months navigating the pandemic impact on the pharmaceutical giant. For BMS, like many organizations, the rapid shift to wide-scale work from home brought some unique challenges. "We're putting a lot more resources into protecting our systems, our information, and a lot more resources into educating our employees that maybe didn't have to worry about securing information themselves," Roberts says. "Our adversaries, not just nation-states, but also criminal organizations are very active ... and relentless." This is, of course, not unique to the pharmaceutical industry, but it is why there needs to be a constant focus on educating the workforce and reinforcing protections, says Roberts.
To read this article in full, please click here
Support the originator by clicking the read the rest link below.
